drug development Related News
A boost for NervGen’s spinal cord injury trials
Following the success of its phase I clinical trial, NervGen will initiate a phase Ib/IIa trial as early as Q3 this year to demonstrate...
How the potential of biosimilar medications can be unlocked
Health Europa details everything you need to know about biosimilar medications, their benefits, safety, success stories, and how biosimilars can revolutionise healthcare.
The potential of...
Defence Therapeutics successfully develops ACCUMTM -mRNA cancer vaccine
Canadian biopharmaceutical pioneer Defence Therapeutics has revealed it has successfully conjugated mRNA molecules to AccumTM – a significant breakthrough that looks to enhance the...
Biopharmaceuticals – the complete guide to the future of medicine
Health Europa provides a comprehensive analysis of biopharmaceuticals to evaluate their significant potential to treat a range of diseases and their cost and value...
A new rapid treatment for IIH headaches is in development
A new injectable peptide-based drug, normally used to treat type-2 diabetes, could treat IIH headaches.
A trial conducted by the University of Birmingham has found...
The natural peptide that could reverse obesity-related diseases
Researchers from the University of Birmingham have found that a peptide called PEPITEM could revolutionise the treatment of obesity-related diseases.
Using an animal obesity model,...
Researchers have developed a revolutionary new bone cancer treatment
Researchers from the University of East Anglia (UEA) have developed a new, non-invasive bone cancer treatment that is effective against all primary forms of...
A new targeted treatment for acute myeloid leukaemia has been approved
A new targeted drug for treating acute myeloid leukaemia has been granted authorisation following a study from the University of Helsinki.
The aim of targeted...
Is Lion’s Mane becoming more popular than CBD oil?
Lion’s Mane is a type of edible mushroom growing in popularity worldwide. Learn everything about this supplement and how it matches up to CBD.
The...
Researchers suggest changes to haemophilia treatment
Findings from two University Hospital Bonn studies could lead to significant changes in haemophilia treatment.
Haemophilia A, which almost exclusively affects males, is the most...
Common heartburn drugs could accelerate TB treatment
Researchers have found that over-the-counter heartburn medications could shorten tuberculosis (TB) treatment.
TB typically takes months to treat, using a range of drugs. As a...
New CAR T-cell therapy offers new hope to ovarian cancer patients
CAR T-cell therapy has shown to be effective in mice with ovarian cancer, offering new hope to patients who require effective treatment.
CAR T-cell therapy...
Using AI to accelerate drug discovery
Artificial Intelligence (AI) can potentially reduce the cost and speed-up drug discovery, according to researchers at the University of Sheffield and AstraZeneca.
The new AI...
Researchers find a new drug candidate for fatty liver disease
A study from Karolinska Institutet has identified a potential antibody drug candidate for the treatment of non-alcoholic fatty liver disease.
Currently, there is no drug...
Improving migraine relief medication
Researchers from Malmö University have found a way to improve migraine relief medication by creating a shortcut from the mucous membrane in the mouth...
Researchers discover that piperlongumine can be used to treat COVID-19
Researchers have reported that the antiviral compound, piperlongumine, can be used in the treatment of COVID-19.
The researchers found that piperlongumine, a compound extracted from...
Oxford University leading research on programmable nucleic acid drugs
A consortium led by the University of Oxford researchers has been awarded £8m of funding to unlock the potential of programmable nucleic acid drugs.
Programmable...
EU regulation does not consider environmental emissions of pharmaceuticals
New research reveals that EU regulation is not currently considering the environmental emissions of pharmaceuticals in global manufacturing supply chains.
The EU regulation that covers...
A new cure for dystonia is under development
A research team in Korea have made significant steps towards finding a cure for dystonia, offering hope to thousands of musicians.
Musicians’ dystonia affects 1-3%...
UCL team gain access to the most powerful supercomputer for drug discovery
A UCL-led team of researchers are using the world’s first exascale supercomputer to identify a shortlist of potential new drugs for diseases.
The supercomputer called...
